Category: Regulatory Affairs
-
Inside Vinay Prasad’s Short Tenure at the FDA: What Led to His Exit and What It Means
Estimated reading time: 4 minutes Key Takeaways Dr. Vinay Prasad’s brief tenure at the FDA was marked by controversy, especially around the Sarepta gene therapy approval. His departure, after less than three months, was influenced by political, industry pressures, and social media backlash. The incident raises concerns about the FDA’s independence and handling of controversial…
-
Dr. Vinay Prasad’s Sudden FDA Departure: What Happened and Why It Matters
Estimated reading time: 4 minutes Key Takeaways Dr. Vinay Prasad resigned from the FDA after a brief tenure of less than three months amid controversy. His departure highlights ongoing tensions between scientific rigor and political influences in regulatory decisions. The case of the Duchenne muscular dystrophy gene therapy debate exemplifies challenges in balancing innovation with…